Assessing the effectiveness and toxicity associated with conditioning protocol for autologous stem cell transplantation in lymphoma cases: Lomustine used in association with etoposide and cyclophosphamide

niversidade Federal de Juiz de Fora0 sitesStarted: February 23, 2022Last updated: May 29, 2023

Conditions

Trial Snapshot

No summary available.

•The study will include patients chemosensitive with LH and LNH younger than 60 years, who present performance status higher than 70% Karnofsky and normal cardiac function ejection fraction > 50%, who do not have chronic respiratory disease expiratory volume in one second > 50%, who have normal liver and kidney function, who are in partial or full disease remission, who present creatinine level lower than 2.0 mg/dL at the beginning of conditioning, and who tested negative for human immunodeficiency virus and hepatitis. All study participants will be eligible to aHSCT therefore, they will meet the criteria presented above.

•Patients who do not meet the established inclusion criteria or who do not agree to participate or not sign the free and informed consent form.

Sponsor

niversidade Federal de Juiz de Fora